Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 422-433, January 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sreekantaiah, C.
Right arrow Articles by Sandberg, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sreekantaiah, C.
Right arrow Articles by Sandberg, A. A.

Cytogenetic Profile of 109 Lipomas1

Chandrika Sreekantaiah2, Stanley P. L. Leong3, Constantine P. Karakousis, Daniel L. McGee, William D. Rappaport, Hugo V. Villar, David Neal, Susan Fleming, Albert Wankel, Peter N. Herrington, Richard Carmona and Avery A. Sandberg4

The Cancer Center of Genetrix, Scottsdale, Arizona 85251 [C. S., A. A. S.]; The Arizona Cancer Center [S. P. L. L., D. L. M., H. V.], Departments of Surgery [S. P. L. L., W. D. R., H. V.] and Biostatistics [D. L. M.], University of Arizona College of Medicine, Tucson, Arizona 85724; Roswell Park Memorial Institute, Buffalo, New York 14263 [C. P. K.]; Cigna Healthplan of Arizona, Tucson, Arizona 85712 [D. N., S. F., A. W.]; Tucson Medical Center, Tucson, Arizona 85712 [R. C.]; and Thomas-Davis Clinic, Tucson, Arizona 85711 [P. N. H.]

Cytogenetic analysis of short-term cultures was carried out on 109 lipomas from 92 patients. Clonal chromosomal abnormalities were present in 50% of the tumors analyzed. Based on the results, three main cytogenetic groups were identified and included: (a) tumors with normal karyotypes, (b) tumors with abnormalities involving region q13–15 on chromosome 12, and (c) tumors with other clonal aberrations. Within each of these groups, cytogenetic subgroups could be identified, each characterized by a specific anomaly. Tumors with abnormalities of 12q included specific subgroups with t/ins(1;12)(p32–33;q13–15), t(2;12)(p21–22;q13–14), t(3;12)(q28;q14), t(12;21)(q13;q21), complex, and nonrecurrent aberrations. The group containing heterogeneous clonal aberrations included subgroups with del(13)(q12q22), der(6)(p21–23), der(11)(q13), and nonspecific aberrations. Chromosome bands 1p36, 1p32–33, 2p21–22, 3q27–28, 6p21–23, 11q13, 12q13–15, 13q12, 13q22, 17p13, 17q21, and 21q21–22 were preferentially involved in structural rearrangements in lipomas. The identification of these sites of nonrandom rearrangements may serve to identify genes (at or near the junctions of chromosomal aberrations) involved in normal cellular growth control. Statistical analysis of the data revealed a correlation among karyotypic abnormalities and clinical data, such as age and sex of the patient, and tumor depth, site, and size.

1 Financial support: Grant CA-41183 from the National Cancer Institute.

2 Present address: Kidwai Memorial Institute of Oncology, Hosur Road, Bangalose 560 029, India.

3 Recipient of the American Cancer Society Clinical Oncology Career Award, 1987–1990.

4 To whom requests for reprints should be addressed, at The Cancer Center of Southwest Biomedical Research, Institute of Genetrix, 6401 East Thomas Road, Scottsdale, AZ 85251.

Received 7/23/90. Accepted 10/ 1/90.




This article has been cited by other articles:


Home page
J. Med. Genet.Home page
B. Menten, K. Buysse, F. Zahir, J. Hellemans, S. J Hamilton, T. Costa, C. Fagerstrom, G. Anadiotis, D. Kingsbury, B. C McGillivray, et al.
Osteopoikilosis, short stature and mental retardation as key features of a new microdeletion syndrome on 12q14
J. Med. Genet., April 1, 2007; 44(4): 264 - 268.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Fedele, S. Battista, G. Manfioletti, C. M. Croce, V. Giancotti, and A. Fusco
Role of the high mobility group A proteins in human lipomas
Carcinogenesis, October 1, 2001; 22(10): 1583 - 1591.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
C. S. Perlis, M. H. Collins, P. J. Honig, and D. W. Low
Forehead Lipoblastoma Mimicking a Hemangioma
Pediatrics, January 1, 2000; 105(1): 123 - 128.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Y. Hennig, U. Deichert, U. Bonk, B. Thode, S. Bartnitzke, and J. Bullerdiek
Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells
Mol. Hum. Reprod., December 1, 1999; 5(12): 1150 - 1154.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. C. Morton
Many Tumors and Many Genes : Genetics of Uterine Leiomyomata
Am. J. Pathol., October 1, 1998; 153(4): 1015 - 1020.
[Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. K. Slany, C. Lavau, and M. L. Cleary
The Oncogenic Capacity of HRX-ENL Requires the Transcriptional Transactivation Activity of ENL and the DNA Binding Motifs of HRX
Mol. Cell. Biol., January 1, 1998; 18(1): 122 - 129.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.